Japan Faces India Push For Greater Share Of Global Generics Markets
This article was originally published in PharmAsia News
Japan, Europe and the U.S. face an influx of Indian generics as the industry pushes to gain greater share of the global market with government’s help.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.